Chris Mancill
Board Member, AstraZeneca
Chris Mancill is listed as Board Member, AstraZeneca. Chris is scheduled to speak at World Evidence, Pricing and Access Congress USA on 15 September 2027.
Compiled from published conference agendas; not yet confirmed by Chris. Is this you? Claim this profile.
About
Chris is the Senior Vice President and Head of US Market Access at AstraZeneca. In this role, he oversees efforts to communicate the value proposition of AstraZeneca's product portfolio to payers, the US government, and other key access stakeholders. Additionally, he leads initiatives to develop innovative solutions that ensure appropriate patient access to the company’s products. Prior to joining AstraZeneca, Chris held senior leadership positions in market access at Bristol Myers Squibb, including serving as the Senior Vice President and Head of Global Market Access, Pricing, and Value Demonstration and earlier as Senior Vice President, US Market Access & Pricing. He has a proven track record of success in market access across both domestic and international markets, with over three decades of experience in the healthcare industry. Throughout his career, Chris has held leadership roles in the innovative biopharmaceutical industry, including at Amgen, Merck Serono, and MorphoSys (
Upcoming
World Evidence, Pricing and Access Congress USA 14 September 2027 – 15 September 2027
- The Modernization of Specialty Pharmacy: How Have the Roles of Key Stakeholders Shifted in the Access Journey? Speaker · 15 September 2027
Spoke alongside
People who have shared a session with Chris at events on B2DB.
- Aleata Postell Senior Vice President Pharmacy Business Development · Humana 1 shared session
- Annette Powers Global Senior VP, Value Access & Public Policy · Astellas 1 shared session
- Linsey Krueger Healthcare Executive · Prime Therapeutics 1 shared session
- Mike Baldzicki Vice President Specialty Pharmacy Biopharma Access & Growth · Walgreens 1 shared session
- Saira Jan Vice President and Chief Pharmacy Officer · Horizon Blue Cross Blue Shield of New Jersey 1 shared session
- William Shrank Chief Executive Officer · Aradigm 1 shared session
Others from AstraZeneca
- Paul Hudson President, AstraZeneca US and Executive Vice President, North America 5 sessions
- Jarosław Oleszczuk Speaker 4 sessions
- Shaun Grady Chair of AstraZeneca UK 4 sessions
- Gabriel Wong Senior Director Physician, Clinical Research, Immunology 3 sessions
- Olga Obrezanova Principal Scientist, Augmented Biologics Design 3 sessions
- Agnieszka Jozwik Senior Research Scientist, Functional Genomics 2 sessions
- Christof Jaeger Senior Director - Data Science & Modelling - Substance, Pharmaceutical Sciences 2 sessions
- Goran Dahl Associate Principal Scientist 2 sessions
- James Fleming Scientist 2 sessions
- Jarrod Walsh Director of Biochemical & Biophysical Screening 2 sessions
- Melanie Leveridge Vice President Assays, Profiling & Cell Sciences 2 sessions
- Miranda Cooper Statistical Science Director 2 sessions